Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 1675 of 3173 entries
View as:

A Study to Learn About the Effect of Avelumab First-Line Maintenance in Canadian People With Advanced Bladder Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05699135 Org: User:
Start: 03/09/23 End: 06/30/23 Due: 06/30/24

Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study Of PF-06291874 As Oral Monotherapy To Treat Adults With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT02175121 Org: User:
Start: 08/31/14 End: 03/31/15 Due: 03/31/16

Non-Interventional Retrospective Correlation Of Tumor Mutational Status To Clinical Benefit Of GIST Patients Treated With Sunitinib

Phase: N/A Priority: Normal
NCT ID: NCT01459757 Org: User:
Start: 10/31/11 End: 04/30/13 Due: 04/30/14

A Real-life Study to Learn About the Use and Effects of the CDK4/6 Inhibitors in Canadian Patients With Breast Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT05770713 Org: User:
Start: 10/12/22 End: 02/28/23 Due: 02/28/24

Long Term Safety and Efficacy Study of Tanezumab in Japanese Adult Subjects With Chronic Low Back Pain

Phase: N/A Priority: Normal
NCT ID: NCT02725411 Org: User:
Start: 05/26/16 End: 06/11/19 Due: 06/11/20

PK And Safety Study Of PF-04171327 In Healthy Japanese And Western Subjects In Fasting And Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01362673 Org: User:
Start: 05/31/11 End: 08/31/11 Due: 08/31/12

A Prospective, Randomized, Placebo and Active Comparator Controlled Study of CP-690,550 in Subjects With Dry Eye.

Phase: N/A Priority: Normal
NCT ID: NCT00784719 Org: User:
Start: 11/30/08 End: 10/31/09 Due: 10/31/10

Multiple IV Dose Study Of PF-04360365 In Patients With Mild To Moderate Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00722046 Org: User:
Start: 12/05/08 End: 08/16/11 Due: 08/16/12

A Study on 2 Different Combination Tablets of Nirmatrelvir Plus Ritonavir to Compare Them With Marketed Paxlovid in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT06397144 Org: User:
Start: 02/14/25 End: 06/10/25 Due: 06/10/26

Efficacy and Safety Study of Rimegepant for Migraine Prevention in Japanese Subjects (Japan Only)

Phase: N/A Priority: Normal
NCT ID: NCT05399485 Org: User:
Start: 08/09/22 End: 11/30/24 Due: 11/30/25

UK Ibrance Patient Program (IPP) Study

Phase: N/A Priority: Normal
NCT ID: NCT03921866 Org: User:
Start: 03/01/19 End: 03/04/21 Due: 03/04/22

A Phase 1 Study To Evaluate The Pharmacokinetics (PK), Safety, And Bioavailability Of A Modified-Release (MR) Formulation Of Tofacitinib In Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01731327 Org: User:
Start: 11/30/12 End: 12/31/12 Due: 12/31/13

Effect of PF-04360365 On ABETA In Patients With Alzheimer's Disease And Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01005862 Org: User:
Start: 03/31/10 End: 09/30/12 Due: 09/30/13

A One Year Clinical Trial Assessing the Usefulness and Safety of Inhaled Insulin in Diabetics With COPD

Phase: N/A Priority: Normal
NCT ID: NCT00138671 Org: User:
Start: 01/31/03 End: 09/30/08 Due: 09/30/09

A Methodological Open Label Cross-Over Controlled Study To Assess The Effect Of Drugs On Ventricular Repolarization and QT Interval At Fixed Heart Rate Under Autonomic Blockade

Phase: N/A Priority: Normal
NCT ID: NCT00174512 Org: User:
Start: 03/31/05 End: 06/30/06 Due: 06/30/07

Heat Wrap Device Safety With Age and Body Fat

Phase: N/A Priority: Normal
NCT ID: NCT01355653 Org: User:
Start: 04/30/11 End: 07/31/11 Due: 07/31/12

Phase 2a, Dose-ranging Study With PF-05221304 in Nonalcoholic Fatty Liver Disease (NAFLD)

Phase: N/A Priority: Normal
NCT ID: NCT03248882 Org: User:
Start: 08/22/17 End: 03/27/19 Due: 03/27/20

Protonix Treatment of Maintenance of Healing in Pediatric Participants Aged 1-11 Years and 12-17 Years

Phase: N/A Priority: Normal
NCT ID: NCT04821310 Org: User:
Start: 01/13/22 End: 05/09/30 Due: 05/09/31

A Study to Determine the Efficacy and Safety of Cabergoline for the Treatment of Patients With RLS

Phase: N/A Priority: Normal
NCT ID: NCT00625547 Org: User:
Start: 01/31/03 End: 12/31/04 Due: 12/31/05

This Is An Open-Label, Non-Comparative Study Designed To Evaluate A Short Course Of IV Anidulafungin, Followed Optionally By Oral Voriconazole, For The Treatment Of Candidemia And Invasive Candidiasis

Phase: N/A Priority: Normal
NCT ID: NCT00548262 Org: User:
Start: 02/29/08 End: 10/31/09 Due: 10/31/10

A Study To Evaluate A Booster Dose Of Menacwy-tt Vaccine Administered 10 Years After Healthy Subjects Aged 11-17 Years Received Either Menacwy-tt Vaccine (Nimenrix(Registered)) Or Mencevax Acwy(Registered).

Phase: N/A Priority: Normal
NCT ID: NCT03189745 Org: User:
Start: 08/01/17 End: 04/11/18 Due: 04/11/19

A Study of a Single Dose of Inclacumab to Reduce Re-admission in Participants With Sickle Cell Disease and Recurrent Vaso-occlusive Crises

Phase: N/A Priority: Normal
NCT ID: NCT04927247 Org: User:
Start: 12/09/21 End: 11/24/23 Due: 11/24/24

A Long-Term Study To Examine The Effects Of CP-945,598 On Weight Loss And Safety

Phase: N/A Priority: Normal
NCT ID: NCT00375401 Org: User:
Start: 10/31/06 End: 01/31/09 Due: 01/31/10

A 52-Week Study of Ritlecitinib Oral Capsules in Adults and Adolescents With Nonsegmental Vitiligo (Active and Stable) Tranquillo

Phase: N/A Priority: Normal
NCT ID: NCT05583526 Org: User:
Start: 12/01/22 End: 04/27/26 Due: 04/27/27

BESPONSA Injection 1 mg Special Investigation

Phase: N/A Priority: Normal
NCT ID: NCT05923112 Org: User:
Start: 07/02/18 End: 09/06/24 Due: 09/06/25